DYN
Dyne Therapeutics Inc
Price:  
25.73 
USD
Volume:  
838,841.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

DYN WACC - Weighted Average Cost of Capital

The WACC of Dyne Therapeutics Inc (DYN) is 7.2%.

The Cost of Equity of Dyne Therapeutics Inc (DYN) is 10.65%.
The Cost of Debt of Dyne Therapeutics Inc (DYN) is 5.00%.

Range Selected
Cost of equity 9.10% - 12.20% 10.65%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.4% - 7.9% 7.2%
WACC

DYN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.14 1.31
Additional risk adjustments 0.0% 0.5%
Cost of equity 9.10% 12.20%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.4% 7.9%
Selected WACC 7.2%